The Massachusetts Senate Committee on Cannabis Policy voted today to advance a bill ordering a study of several marijuana proposals, including a temporary pause on certain license types, dedicating a portion of excise taxes to youth prevention, new product labeling rules, and limits on THC potency. Senate Bill 2677 directs the Cannabis Policy Committee to …
Study: Medical Marijuana, Especially CBD-Rich Enteral Products, Reduces Anxiety and Depression in Cancer Patients
A large study published in Cancer Medicine has found that medical marijuana can ease anxiety and depression in cancer patients, with outcomes influenced by dosage and method of use. Researchers from the University of Wisconsin-Madison and the Minnesota Office of Cannabis Management analyzed data from 1,962 cancer patients enrolled in the Minnesota Medical Cannabis Program. …
Study: Inhaled Cannabis Provides Long-Term Pain Relief and Reduces Opioid Use in Diabetic Neuropathy Patients
A new study published in the journal Biomedicines has found that inhaled cannabis can provide lasting benefits for patients suffering from painful diabetic neuropathy (DN), a common complication of diabetes that affects up to half of long-term patients. The five-year observational study followed 52 patients who had failed to respond to at least three conventional …
Study: Cannabis Use Not Linked to Blood Clot Risk in Trauma Patients
According to a study published in the peer-reviewed journal American Surgeon, there’s no evidence that cannabis use increases the risk of blood clots or alters coagulation-related biomarkers in adolescent and adult trauma patients. For the study, researchers reviewed records of 302 patients admitted to a level one trauma center between October 2019 and December 2023, …
Clinical Trial Finds Cannabis Extract With THC and CBD Improves Cognitive Function in Patients With Alzheimer’s-Related Dementia
A phase 2 clinical trial published in the Journal of Alzheimer’s Disease suggests that low-dose THC-CBD extract may improve cognitive function in patients with Alzheimer’s-related dementia. “We designed this trial to evaluate the safety and efficacy of low-dose THC-CBD balanced cannabinoid extract in the treatment of patients with AD-associated dementia”, states the research team consisting …
Signature Drives to Place Cannabis Initiatives on 2026 Ballot Underway in Four States: Oklahoma, Florida, Oregon, and Idaho
Signature drives to reform state cannabis laws are now underway in Oklahoma, Oregon, Florida and Idaho, with each campaign aiming for the November 2026 ballot. Below is a state-by-state breakdown of these campaigns:
Study Finds Thyme Essential Oil and Cannabinoids Show Synergistic Benefits for Inflammatory Skin Conditions
A study published recently in the journal Pharmaceutics finds that combining thyme essential oil with cannabinoids could help treat inflammatory skin disorders such as atopic dermatitis, psoriasis, and acne. Researchers from the Universidade de Lisboa focused on Thymus mastichina essential oil, which is rich in terpenes like thymol, linalool, eucalyptol, α-terpineol, γ-terpinene, and terpinolene. The …
Idaho Medical Cannabis Legalization Initiative Clears Hurdle, Campaign Launches Signature Drive
An Idaho campaign to legalize medical marijuana has officially gained state approval to begin gathering signatures to place an initiative on the 2026 general election ballot. The Idaho Medical Cannabis Act, backed by the Natural Medicine Alliance of Idaho, would create a tightly regulated program allowing patients with serious medical conditions to access marijuana under …
Federal Court Upholds Wyoming’s Ban on Intoxicating Hemp Products
The 10th Circuit Court of Appeals has upheld Wyoming’s 2024 law banning intoxicating hemp products such as delta-8 THC, ruling that the state acted within its authority despite arguments that the statute conflicts with the federal 2018 Farm Bill. The case was filed by Green Room LLC of Casper along with 10 other hemp retailers, …
Cannabidivarin (CBDV) May Enhance Immune Response Against Cancer by Targeting Suppressor Cells, Study Finds
A new study published in Biomed Pharmacotherapy finds that cannabidivarin (CBDV), a non-psychoactive cannabinoid, may have significant potential as an immunotherapy agent for cancer. Researchers at the Technion-Israel Institute of Technology found that CBDV directly reprograms myeloid suppressor cells, which are key drivers of immunosuppression in the tumor microenvironment. These cells, including Myeloid-Derived Suppressor Cells …
